Skip to content
Business Times – Lifestyle
Author:
CancerVAX, Inc
CancerVax Successfully Kills Cancer Cells in Landmark Test
November 17, 2026
CancerVax Achieves Major Milestone in Activating Human Killer T-Cells Against Cancer
August 6, 2026
CancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review
July 28, 2026
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
July 14, 2026
CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
June 15, 2026